Copyright Reports & Markets. All rights reserved.

Global Colchicine Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Colchicine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Colchicine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Colchicine Market Size Growth Rate by Type
    • 1.4.2 Tablet
    • 1.4.3 Oral Solution
  • 1.5 Market by Application
    • 1.5.1 Global Colchicine Market Size Growth Rate by Application
    • 1.5.2 Acute Gout
    • 1.5.3 Chronic Gout
    • 1.5.4 Other Conditions
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Colchicine Market Size, Estimates and Forecasts
    • 2.1.1 Global Colchicine Revenue 2015-2026
    • 2.1.2 Global Colchicine Sales 2015-2026
  • 2.2 Global Colchicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Colchicine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Colchicine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Colchicine Competitor Landscape by Players

  • 3.1 Colchicine Sales by Manufacturers
    • 3.1.1 Colchicine Sales by Manufacturers (2015-2020)
    • 3.1.2 Colchicine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Colchicine Revenue by Manufacturers
    • 3.2.1 Colchicine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Colchicine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Colchicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Colchicine Revenue in 2019
    • 3.2.5 Global Colchicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Colchicine Price by Manufacturers
  • 3.4 Colchicine Manufacturing Base Distribution, Product Types
    • 3.4.1 Colchicine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Colchicine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Colchicine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Colchicine Market Size by Type (2015-2020)
    • 4.1.1 Global Colchicine Sales by Type (2015-2020)
    • 4.1.2 Global Colchicine Revenue by Type (2015-2020)
    • 4.1.3 Colchicine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Colchicine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Colchicine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Colchicine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Colchicine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Colchicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Colchicine Market Size by Application (2015-2020)
    • 5.1.1 Global Colchicine Sales by Application (2015-2020)
    • 5.1.2 Global Colchicine Revenue by Application (2015-2020)
    • 5.1.3 Colchicine Price by Application (2015-2020)
  • 5.2 Colchicine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Colchicine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Colchicine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Colchicine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Colchicine by Country
    • 6.1.1 North America Colchicine Sales by Country
    • 6.1.2 North America Colchicine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Colchicine Market Facts & Figures by Type
  • 6.3 North America Colchicine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Colchicine by Country
    • 7.1.1 Europe Colchicine Sales by Country
    • 7.1.2 Europe Colchicine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Colchicine Market Facts & Figures by Type
  • 7.3 Europe Colchicine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Colchicine by Region
    • 8.1.1 Asia Pacific Colchicine Sales by Region
    • 8.1.2 Asia Pacific Colchicine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Colchicine Market Facts & Figures by Type
  • 8.3 Asia Pacific Colchicine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Colchicine by Country
    • 9.1.1 Latin America Colchicine Sales by Country
    • 9.1.2 Latin America Colchicine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Colchicine Market Facts & Figures by Type
  • 9.3 Central & South America Colchicine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Colchicine by Country
    • 10.1.1 Middle East and Africa Colchicine Sales by Country
    • 10.1.2 Middle East and Africa Colchicine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Colchicine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Colchicine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Takeda Pharmaceuticals
    • 11.1.1 Takeda Pharmaceuticals Corporation Information
    • 11.1.2 Takeda Pharmaceuticals Description and Business Overview
    • 11.1.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Takeda Pharmaceuticals Colchicine Products Offered
    • 11.1.5 Takeda Pharmaceuticals Related Developments
  • 11.2 Hikma
    • 11.2.1 Hikma Corporation Information
    • 11.2.2 Hikma Description and Business Overview
    • 11.2.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Hikma Colchicine Products Offered
    • 11.2.5 Hikma Related Developments
  • 11.3 Cipla
    • 11.3.1 Cipla Corporation Information
    • 11.3.2 Cipla Description and Business Overview
    • 11.3.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Cipla Colchicine Products Offered
    • 11.3.5 Cipla Related Developments
  • 11.4 Wockhardt
    • 11.4.1 Wockhardt Corporation Information
    • 11.4.2 Wockhardt Description and Business Overview
    • 11.4.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Wockhardt Colchicine Products Offered
    • 11.4.5 Wockhardt Related Developments
  • 11.5 West-Ward
    • 11.5.1 West-Ward Corporation Information
    • 11.5.2 West-Ward Description and Business Overview
    • 11.5.3 West-Ward Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 West-Ward Colchicine Products Offered
    • 11.5.5 West-Ward Related Developments
  • 11.6 Excellium Pharmaceutical
    • 11.6.1 Excellium Pharmaceutical Corporation Information
    • 11.6.2 Excellium Pharmaceutical Description and Business Overview
    • 11.6.3 Excellium Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Excellium Pharmaceutical Colchicine Products Offered
    • 11.6.5 Excellium Pharmaceutical Related Developments
  • 11.7 Rhea Pharmaceutical
    • 11.7.1 Rhea Pharmaceutical Corporation Information
    • 11.7.2 Rhea Pharmaceutical Description and Business Overview
    • 11.7.3 Rhea Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Rhea Pharmaceutical Colchicine Products Offered
    • 11.7.5 Rhea Pharmaceutical Related Developments
  • 11.8 Medinova
    • 11.8.1 Medinova Corporation Information
    • 11.8.2 Medinova Description and Business Overview
    • 11.8.3 Medinova Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Medinova Colchicine Products Offered
    • 11.8.5 Medinova Related Developments
  • 11.9 Odan Laboratories
    • 11.9.1 Odan Laboratories Corporation Information
    • 11.9.2 Odan Laboratories Description and Business Overview
    • 11.9.3 Odan Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Odan Laboratories Colchicine Products Offered
    • 11.9.5 Odan Laboratories Related Developments
  • 11.10 Prasco
    • 11.10.1 Prasco Corporation Information
    • 11.10.2 Prasco Description and Business Overview
    • 11.10.3 Prasco Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Prasco Colchicine Products Offered
    • 11.10.5 Prasco Related Developments
  • 11.1 Takeda Pharmaceuticals
    • 11.1.1 Takeda Pharmaceuticals Corporation Information
    • 11.1.2 Takeda Pharmaceuticals Description and Business Overview
    • 11.1.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Takeda Pharmaceuticals Colchicine Products Offered
    • 11.1.5 Takeda Pharmaceuticals Related Developments
  • 11.12 Yunnan Plant Medicine
    • 11.12.1 Yunnan Plant Medicine Corporation Information
    • 11.12.2 Yunnan Plant Medicine Description and Business Overview
    • 11.12.3 Yunnan Plant Medicine Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Yunnan Plant Medicine Products Offered
    • 11.12.5 Yunnan Plant Medicine Related Developments
  • 11.13 Xishuangbanna Pharmaceutical
    • 11.13.1 Xishuangbanna Pharmaceutical Corporation Information
    • 11.13.2 Xishuangbanna Pharmaceutical Description and Business Overview
    • 11.13.3 Xishuangbanna Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Xishuangbanna Pharmaceutical Products Offered
    • 11.13.5 Xishuangbanna Pharmaceutical Related Developments
  • 11.14 Guangdong Pedi
    • 11.14.1 Guangdong Pedi Corporation Information
    • 11.14.2 Guangdong Pedi Description and Business Overview
    • 11.14.3 Guangdong Pedi Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Guangdong Pedi Products Offered
    • 11.14.5 Guangdong Pedi Related Developments
  • 11.15 Yunnan Shan State
    • 11.15.1 Yunnan Shan State Corporation Information
    • 11.15.2 Yunnan Shan State Description and Business Overview
    • 11.15.3 Yunnan Shan State Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Yunnan Shan State Products Offered
    • 11.15.5 Yunnan Shan State Related Developments
  • 11.16 Tonghua Limin
    • 11.16.1 Tonghua Limin Corporation Information
    • 11.16.2 Tonghua Limin Description and Business Overview
    • 11.16.3 Tonghua Limin Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Tonghua Limin Products Offered
    • 11.16.5 Tonghua Limin Related Developments
  • 11.17 Beijing Jialin Pharmaceutical
    • 11.17.1 Beijing Jialin Pharmaceutical Corporation Information
    • 11.17.2 Beijing Jialin Pharmaceutical Description and Business Overview
    • 11.17.3 Beijing Jialin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Beijing Jialin Pharmaceutical Products Offered
    • 11.17.5 Beijing Jialin Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Colchicine Market Estimates and Projections by Region
    • 12.1.1 Global Colchicine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Colchicine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Colchicine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Colchicine Sales Forecast (2021-2026)
    • 12.2.2 North America: Colchicine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Colchicine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Colchicine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Colchicine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Colchicine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Colchicine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Colchicine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Colchicine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Colchicine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Colchicine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Colchicine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Colchicine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Colchicine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Colchicine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Colchicine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Colchicine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Colchicine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Colchicine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Colchicine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Colchicine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Colchicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colchicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Colchicine market is segmented into
    Tablet
    Oral Solution

    Segment by Application, the Colchicine market is segmented into
    Acute Gout
    Chronic Gout
    Other Conditions

    Regional and Country-level Analysis
    The Colchicine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Colchicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Colchicine Market Share Analysis
    Colchicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Colchicine business, the date to enter into the Colchicine market, Colchicine product introduction, recent developments, etc.

    The major vendors covered:
    Takeda Pharmaceuticals
    Hikma
    Cipla
    Wockhardt
    West-Ward
    Excellium Pharmaceutical
    Rhea Pharmaceutical
    Medinova
    Odan Laboratories
    Prasco
    Kunming Pharmaceutical
    Yunnan Plant Medicine
    Xishuangbanna Pharmaceutical
    Guangdong Pedi
    Yunnan Shan State
    Tonghua Limin
    Beijing Jialin Pharmaceutical

    Buy now